Abstract
What a Clinical Trial Related to Elective Labor Induction Could Mean for the Future of Birth in the United States Many perinatal providers are unaware that a large, multi-site clinical trial is currently underway to compare elective induction of labor at 39 weeks gestation to expectant management in nulliparous women with single, vertex fetuses. This study, known as A Randomized Trial of Induction Versus Expectant Management (ARRIVE), has the capacity to radically change the way late pregnancy and labor are managed in the United States (ClinicalTrials.gov, 2015).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
